BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17445772)

  • 1. Involvement of the betaTrCP in the ubiquitination and stability of the HIV-1 Vpu protein.
    Belaïdouni N; Marchal C; Benarous R; Besnard-Guérin C
    Biochem Biophys Res Commun; 2007 Jun; 357(3):688-93. PubMed ID: 17445772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulated degradation of the HIV-1 Vpu protein through a betaTrCP-independent pathway limits the release of viral particles.
    Estrabaud E; Le Rouzic E; Lopez-Vergès S; Morel M; Belaïdouni N; Benarous R; Transy C; Berlioz-Torrent C; Margottin-Goguet F
    PLoS Pathog; 2007 Jul; 3(7):e104. PubMed ID: 17676996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. βTrCP is Required for HIV-1 Vpu Modulation of CD4, GaLV Env, and BST-2/Tetherin.
    Song YE; Cyburt D; Lucas TM; Gregory DA; Lyddon TD; Johnson MC
    Viruses; 2018 Oct; 10(10):. PubMed ID: 30347660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway.
    Schubert U; Antón LC; Bacík I; Cox JH; Bour S; Bennink JR; Orlowski M; Strebel K; Yewdell JW
    J Virol; 1998 Mar; 72(3):2280-8. PubMed ID: 9499087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism.
    Douglas JL; Viswanathan K; McCarroll MN; Gustin JK; Früh K; Moses AV
    J Virol; 2009 Aug; 83(16):7931-47. PubMed ID: 19515779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 Vpu sequesters beta-transducin repeat-containing protein (betaTrCP) in the cytoplasm and provokes the accumulation of beta-catenin and other SCFbetaTrCP substrates.
    Besnard-Guerin C; Belaïdouni N; Lassot I; Segeral E; Jobart A; Marchal C; Benarous R
    J Biol Chem; 2004 Jan; 279(1):788-95. PubMed ID: 14561767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B.
    Bour S; Perrin C; Akari H; Strebel K
    J Biol Chem; 2001 May; 276(19):15920-8. PubMed ID: 11278695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitination of BST-2 protein by HIV-1 Vpu protein does not require lysine, serine, or threonine residues within the BST-2 cytoplasmic domain.
    Gustin JK; Douglas JL; Bai Y; Moses AV
    J Biol Chem; 2012 Apr; 287(18):14837-50. PubMed ID: 22383521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of β-TrcP-dependent ubiquitination of p53 by HIV-1 Vpu promotes p53-mediated apoptosis in human T cells.
    Verma S; Ali A; Arora S; Banerjea AC
    Blood; 2011 Jun; 117(24):6600-7. PubMed ID: 21521785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 Vpu utilizes both cullin-RING ligase (CRL) dependent and independent mechanisms to downmodulate host proteins.
    Ramirez PW; DePaula-Silva AB; Szaniawski M; Barker E; Bosque A; Planelles V
    Retrovirology; 2015 Jul; 12():65. PubMed ID: 26215564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR studies of the phosphorylation motif of the HIV-1 protein Vpu bound to the F-box protein beta-TrCP.
    Coadou G; Gharbi-Benarous J; Megy S; Bertho G; Evrard-Todeschi N; Segeral E; Benarous R; Girault JP
    Biochemistry; 2003 Dec; 42(50):14741-51. PubMed ID: 14674748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid degradation of CD4 in cells expressing human immunodeficiency virus type 1 Env and Vpu is blocked by proteasome inhibitors.
    Fujita K; Omura S; Silver J
    J Gen Virol; 1997 Mar; 78 ( Pt 3)():619-25. PubMed ID: 9049413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor kappaB-dependent expression of antiapoptotic factors.
    Akari H; Bour S; Kao S; Adachi A; Strebel K
    J Exp Med; 2001 Nov; 194(9):1299-311. PubMed ID: 11696595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UV-induced degradation of securin is mediated by SKP1-CUL1-beta TrCP E3 ubiquitin ligase.
    Limón-Mortés MC; Mora-Santos M; Espina A; Pintor-Toro JA; López-Román A; Tortolero M; Romero F
    J Cell Sci; 2008 Jun; 121(11):1825-31. PubMed ID: 18460583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR studies for identifying phosphopeptide ligands of the HIV-1 protein Vpu binding to the F-box protein beta-TrCP.
    Evrard-Todeschi N; Gharbi-Benarous J; Bertho G; Coadou G; Megy S; Benarous R; Girault JP
    Peptides; 2006 Jan; 27(1):194-210. PubMed ID: 16165251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyubiquitination of the B-cell translocation gene 1 and 2 proteins is promoted by the SCF ubiquitin ligase complex containing βTrCP.
    Sasajima H; Nakagawa K; Kashiwayanagi M; Yokosawa H
    Biol Pharm Bull; 2012; 35(9):1539-45. PubMed ID: 22975506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 Vpu Downmodulates ICAM-1 Expression, Resulting in Decreased Killing of Infected CD4
    Sugden SM; Pham TNQ; Cohen ÉA
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirements for the selective degradation of CD4 receptor molecules by the human immunodeficiency virus type 1 Vpu protein in the endoplasmic reticulum.
    Binette J; Dubé M; Mercier J; Halawani D; Latterich M; Cohen EA
    Retrovirology; 2007 Oct; 4():75. PubMed ID: 17937819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vpu-dependent block to incorporation of GaLV Env into lentiviral vectors.
    Christodoulopoulos I; Droniou-Bonzom ME; Oldenburg JE; Cannon PM
    Retrovirology; 2010 Jan; 7():4. PubMed ID: 20102634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vpu-mediated degradation of CD4 reconstituted in yeast reveals mechanistic differences to cellular ER-associated protein degradation.
    Meusser B; Sommer T
    Mol Cell; 2004 Apr; 14(2):247-58. PubMed ID: 15099523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.